The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 11, 2018

Filed:

May. 01, 2014
Applicant:

Api Corporation, Tokyo, JP;

Inventors:

Yuuki Asuma, Kanagawa, JP;

Hisatoshi Uehara, Kanagawa, JP;

Tomoko Maeda, Kanagawa, JP;

Yasuyo Saito, Kanagawa, JP;

Ryoma Miyake, Kanagawa, JP;

Hiroshi Kawabata, Kanagawa, JP;

Assignee:

API Corporation, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 319/06 (2006.01); C07C 323/52 (2006.01); C07C 323/58 (2006.01); C07D 277/14 (2006.01); C07C 319/02 (2006.01); C12P 13/12 (2006.01); C07C 319/14 (2006.01); C07C 319/20 (2006.01); C07C 323/60 (2006.01);
U.S. Cl.
CPC ...
C07C 319/06 (2013.01); C07C 319/02 (2013.01); C07C 319/14 (2013.01); C07C 319/20 (2013.01); C07C 323/52 (2013.01); C07C 323/58 (2013.01); C07C 323/60 (2013.01); C07D 277/14 (2013.01); C12P 13/12 (2013.01);
Abstract

According to the present invention, it becomes possible to perform a process for converting into an α-substituted cysteine represented by general formula (1) or a salt thereof at low cost and on an industrial scale by employing a process that is routed through a compound represented by general formula (3) to a compound represented by general formula (6). Particularly, by employing a process that is routed through a compound represented by general formula (7-2), it becomes possible to detach a tert-butyl protection group in a simple manner and to produce the compound represented by general formula (1) with high purity. Furthermore, by employing a process that is routed through tert-butylthiomethanol or a process that is routed through a compound represented by general formula (9), it becomes possible to produce a compound represented by general formula (2) without generating bischloromethylether that is an oncogenic substance. In the production of an α-substituted-D-cysteine or a salt thereof, it becomes possible to perform a process for converting the compound represented by general formula (2) into a compound represented by general formula (3S) in one step by allowing an enzyme or the like to act on the compound represented by general formula (2).


Find Patent Forward Citations

Loading…